The impact of patient characteristics on the Minimal Clinically Important Difference of COPD health status tools
H. Alma (Groningen, Netherlands), C. De Jong (Groningen, Netherlands), D. Jelusic (Bad Reichenhall, Germany), M. Wittmann (Bad Reichenhall, Germany), M. Schuler (Wuerzburg, Germany), R. Sanderman (Groningen, Netherlands), K. Schultz (Bad Reichenhall, Germany), J. Kocks (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands)
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Alma (Groningen, Netherlands), C. De Jong (Groningen, Netherlands), D. Jelusic (Bad Reichenhall, Germany), M. Wittmann (Bad Reichenhall, Germany), M. Schuler (Wuerzburg, Germany), R. Sanderman (Groningen, Netherlands), K. Schultz (Bad Reichenhall, Germany), J. Kocks (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands). The impact of patient characteristics on the Minimal Clinically Important Difference of COPD health status tools. 2274
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: